David M. Goldstein - 27 Jun 2024 Form 3 Insider Report for ALUMIS INC. (ALMS)

Role: Chief Scientific Officer
Signature: /s/ Sara Klein, Attorney-in-Fact
Issuer symbol: ALMS
Transactions as of: 27 Jun 2024
Net transactions value: $0
Form type: 3
Filing time: 27 Jun 2024, 16:05:05 UTC
Next filing: 01 Jul 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ALMS	Class A Common Stock						213,903	27 Jun 2024	By Trust	F1
holding	ALMS	Class A Common Stock						2,994	27 Jun 2024	By Family Members	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ALMS	Stock Option (Right to Buy)							27 Jun 2024	Class A Common Stock	42,780	$8.84	Direct	F3
holding	ALMS	Stock Option (Right to Buy)							27 Jun 2024	Class A Common Stock	171,122	$8.84	Direct	F4
holding	ALMS	Stock Option (Right to Buy)							27 Jun 2024	Class A Common Stock	11,978	$8.84	Direct	F5
holding	ALMS	Stock Option (Right to Buy)							27 Jun 2024	Class A Common Stock	30,642	$8.84	Direct	F6
holding	ALMS	Stock Option (Right to Buy)							27 Jun 2024	Class A Common Stock	206,074	$10.20	Direct	F7
holding	ALMS	Stock Option (Right to Buy)							27 Jun 2024	Class A Common Stock	53,475	$13.33	Direct	F8

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares are held directly by the Baily Goldstein Living Trust dated March 4, 2014, for which the Reporting Person serves as a trustee.
F2	Shares are held directly by family members of Reporting Person residing in his primary residence.
F3	25% of the shares underlying this option vested on January 27, 2023, and the remaining shares vest in equal monthly installments thereafter over the following 36 months, subject to acceleration and the Reporting Person's continuous service to the Issuer on each such vesting date.
F4	33% of the shares underlying this option vested on January 27, 2024, and the remaining shares vest in equal monthly installments thereafter over the following 48 months, subject to acceleration and the Reporting Person's continuous service to the Issuer on each such vesting date.
F5	25% of the shares underlying this option vested on May 22, 2024, and the remaining shares vest in equal monthly installments thereafter over the following 36 months, subject to acceleration and the Reporting Person's continuous service to the Issuer on each such vesting date.
F6	25% of the shares underlying this option vest on October 9, 2024, and the remaining shares vest in equal monthly installments thereafter over the following 36 months, subject to acceleration and the Reporting Person's continuous service to the Issuer on each such vesting date.
F7	The option vests in three equal installments, subject to the Issuer's satisfaction of certain performance criteria on each of May 6, 2028, May 6, 2029 and May 6, 2030, and subject to acceleration and the Reporting Person's continuous service to the Issuer on each such vesting date.
F8	25% of the shares underlying this option vest on June 6, 2025, and the remaining shares vest in equal monthly installments thereafter over the following 36 months, subject to acceleration and the Reporting Person's continuous service to the Issuer on each such vesting date.